COMMUNIQUÉS West-GlobeNewswire

-
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024
12/06/2024 -
NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
12/06/2024 -
Building Awareness of Mental Health Issues in the Workplace: River Oaks Treatment Center Executive Speaks at Tampa LGBT Chamber of Commerce Luncheon
12/06/2024 -
SAFE - First implantations of the Sycamore device in Switzerland
12/06/2024 -
OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse
12/06/2024 -
SAFE - Premières implantations du dispositif Sycamore en Suisse
12/06/2024 -
Webinaire KOL Investisseurs d’OSE Immunotherapeutics : le paysage thérapeutique et les besoins médicaux non satisfaits dans le cancer du poumon non à petites cellules
12/06/2024 -
AAPS Calls for Overruling Jacobson v. Massachusetts, upon Which Vaccine Mandates Are Based
12/06/2024 -
Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT
12/06/2024 -
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID
12/06/2024 -
Cute Season on Parliament Hill – Announcing the Winners of the 2nd Annual Cutest Pets on Parliament Hill Contest
12/06/2024 -
C’est la saison des animaux les plus mignons sur la Colline du Parlement - Annonce des gagnants du 2e concours annuel « Les animaux de compagnie les plus mignons sur la Colline du Parlement »
12/06/2024 -
Verana Health Committed to Revolutionizing Clinical Trials with Enhancements to SaaS Applications
12/06/2024 -
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
12/06/2024 -
BioSyent In-Licenses Endocrinology Product for Canada
12/06/2024 -
Precipio Provides Status Update on Current Business Matters
12/06/2024 -
Philips launches Duo Venous Stent System for treatment of symptomatic venous outflow obstruction
12/06/2024 -
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
12/06/2024 -
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
12/06/2024
Pages